The Molecular Imaging & Image-Guided Therapy (MIIGT) research program, led by Prof. Mosa Alhamami, focuses on developing advanced image-guided focused ultrasound technologies for interventional applications, advancing cancer imaging through innovative molecular, cellular, and quantitative MRI approaches, and engineering nanomaterials designed to improve the targeted delivery of contrast agents and cancer therapeutics.
Additionally, we are actively exploring artificial intelligence (AI) applications within radiology – with a particular focus on interventional radiology – to optimize clinical workflows, enhance patient safety, improve operational efficiency, strengthen radiation management, and elevate the overall quality of imaging outcomes through informed, data-driven decision-making.